 |
API series |
 |
|
Intermediate series |
|
|
 |
1. WARRANTIES. Chengdu D-innovation Pharmaceutical Co.,Ltd warrants that (a) the product sold is of the quality set forth in Chengdu D-innovation Pharmaceutical Co.,Ltd’s published specifications, if any, or as may be otherwise expressly stated in any negotiated contract, and (b)the title conveyed is good and the product is free from any lawful security interest, lien or encumbrance. CHENGDU D-INNOVATION PHARMACEUTICAL CO.,LTD MAKES NO FURTHER REPRESENTATION OR WARANTIES, EXPRESS OR IMPLIED, OF MERCHANTABILITY OR OTHERWISE.Products protected by valid patents in this list are for laboratory analytical/research purposes only and are not offered for sale in countries or area where the sale of such products constitutes a patent infringement, its liability is at buyer's risk!
2. PRICE AND TERMS.Quotations will only be provided through email (sales@d-innovation.com) to inquirers who have a valid email address from a corporation, university, research institute, or government institution. Price would be stated in US Dollars or Chinese CNY. Special discount will be considered for regular or large orders. If the product is subject to a negotiated contract or purchase order, the contract or purchase order should specify price and/or terms of sale.
3. DELIVERY TERMS. The terms FOB, CIF, C&F or such similar terms are, except as may be agreed to in any negotiated contract, only terms that express delivery terms and payment terms are not an agreement as to passage of title. Productswould be shipped via DHL, an international door to door delivery service. In some case, products would be shipped via TNT etc..
4. PAYMENT.To protect the interests ofChengdu D-innovation Pharmaceutical Co.,Ltd in most transactions,payment would be required as a condition of shipment. For the first-time-customer, 100% payment of a Performa Invoice in advance might be required.
5. TITLE. If the product is subject to a negotiated contract, and the contract does not specify the passage of title and risk of loss, or in the absence of a negotiated contract, title to and risk of loss on all products sold shall pass to Buyer at Chengdu D-innovation Pharmaceutical Co.,Ltd’s point of shipment whether or not Chengdu D-innovation Pharmaceutical Co.,Ltd pays all or any part of the freight, and notwithstanding any designation of FOB or any other delivery term elsewhere in any invoice or document evidencing the sale.
6. FORCE MAJEURE. Neither party shall be liable for its failure to perform if due to any contingency beyond the reasonable control of the party affected, including but not limited to acts of God, war, fire, bad weather, flood, accident, labor trouble or shortage, civil disturbance, plant shutdown, equipment failure, issues involving national security, or voluntary or involuntary compliance with any applicable governmental act, regulation or order. Chengdu D-innovation Pharmaceutical Co.,Ltd shall not be liable for its failure to perform if such failure is due to any shortage or inability to obtain (on terms deemed economically practicable by Chengdu D-innovation Pharmaceutical Co.,Ltd) any raw material (including energy), equipment or transportation.
7. CLAIMS. Claims relating to quantity, quality, weight, condition and loss of or damage to any of the product sold hereunder shall be waived by Buyer unless made within fifteen (15) days after receipt of product by Buyer.
8. CAPTIONS. The titles contained in these Terms and Conditions are for reference purposes only and shall not affect in any way the meaning or interpretationof this document.
9. AMENDMENT. In the absence of a negotiated contract, or if same is silent, these Terms and Conditions are intended as the final expression of the parties’ agreement and are the complete and exclusive statement of the terms thereof. No statements or instructions, oral or written, except as part of a negotiated contract, shall vary or modify these written terms; and neither party shall claim any amendment, modification or release from any provision hereof by reason of (a) a course of action or mutual agreement unless such agreement is in writing signed by the other party and specifically stating it is an amendment to this contract, (b) course of performance or (c) usage of trade. No modification or addition to any contract or sales agreement shall be effected except by the prior written acknowledgement and acceptance by Chengdu D-innovation Pharmaceutical Co.,Ltd of any purchase order, acknowledgement, release or other forms submitted by Buyer containing other or different terms or conditions. |
|
